Agency opinion regarding the next steps for the REVELA 13 monitoring program following the opinion of the Expert Committee on Occupational Health and the Environment

In 2018, the PACA Regional Health Agency (ARS PACA) consulted Santé publique France on the advisability of extending the work of the Observatory for Kidney, Bladder, and Acute Leukemia Cancers in Adults in the Bouches-du-Rhône department to other types of cancer (REVELA 13) (referral 18-A-00255 / DSPE-0718-4564-D dated July 13, 2018).

N.B.: Parts 1, 2, and 3 of the Opinion reproduce the analysis and conclusions formulated by the Health, Environment, and Work Expert Committee (CE SET). Part 4 contains the opinion formulated by Santé publique France, based on the CE’s recommendations.

See also:

In relation to

Our latest news

news

Alcohol Meter: A Review After 6 Years of Use by the French to Assess Their...

news

Extreme heat affects us all: let's adopt the right habits

news

G7 Summit in Evian: Enhanced Health Monitoring